October 11, 2025
The Japan Bioindustry Association (JBA) is delighted to announce the successful conclusion of BioJapan 2025, held from October 8-10, 2025, at Pacifico Yokohama. As Asia's largest biotechnology partnering event, now in its 27th edition since its inaugural launch in 1986, BioJapan 2025 once again demonstrated its vital role as the premier platform for fostering innovation and collaboration across the global life sciences ecosystem.
< Record-Breaking Participation >
22,167 attendees
1,568 participating companies in exhibition and partnering
25,498 business meetings
< Innovation Forum - Inaugural Launch >
BioJapan 2025 introduced the first-ever Investment Forum, creating a dedicated platform for global investors, venture capitalists, and startups. The forum featured presentations by VCs, government agencies including AMED and JETRO, startup pitches from Japan, Taiwan, and South Korea, and panel discussions on biotech investment strategies for startup success.
We extend our sincere gratitude to all participants, exhibitors, sponsors, partners, and government officials who contributed to making BioJapan 2025 an outstanding success. Your engagement, expertise, and collaborative spirit continue to drive innovation in the global biotechnology industry.
< Looking Ahead to BioJapan 2026 >
Following this remarkable success, BioJapan 2026 is scheduled for October 7-9, 2026, at Pacifico Yokohama. Planning is already underway to build upon this year's achievements and further strengthen BioJapan's position as the gateway to Asia's biotechnology markets.
Acknowledgments
For more information about BioJapan and to register your interest for BioJapan 2026, please visit:
https://jcd-expo.jp/en/
< About BioJapan >
BioJapn is organized annually by the BioJapan Organizing Committee, which includes the Japan Business Association (JBA) and JTB Communication Design, Inc. The event offers a comprehensive platform for business development, networking, and knowledge exchange in the life sciences and biotechnologies sector, connecting Japanese companies and Asian companies with global partners and facilitating the growth of the biotechnology industry.
